Hesperetin suppresses RANKL-induced osteoclastogenesis and ameliorates lipopolysaccharide-induced bone loss (vol 234, pg 11009, 2019)

被引：0
|
作者：
Liu, Hui
Dong, Yonghui
Gao, Yutong
Zhao, Liming
Cai, Cong
Qi, Dahu
Zhu, Meipeng
Zhao, Libo
Liu, Changyu
Guo, Fengjing
Xiao, Jun
Huang, Hui
机构：
来源：
JOURNAL OF CELLULAR PHYSIOLOGY | 2021年 / 236卷 / 05期
关键词：
D O I：
10.1002/jcp.30182
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：4091 / 4091
页数：1
相关论文
共 50 条
  • [1] Hesperetin suppresses RANKL-induced osteoclastogenesis and ameliorates lipopolysaccharide-induced bone loss
    Liu, Hui
    Dong, Yonghui
    Gao, Yutong
    Zhao, Liming
    Cai, Cong
    Qi, Dahu
    Zhu, Meipeng
    Zhao, Libo
    Liu, Changyu
    Guo, Fengjing
    Xiao, Jun
    Huang, Hui
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 11009 - 11022
  • [2] Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo
    Peng, Jiaxuan
    Zhao, Kangxian
    Zhu, Jiling
    Wang, Yanben
    Sun, Peng
    Yang, Qichang
    Zhang, Tan
    Han, Weiqi
    Hu, Wenjun
    Yang, Wanlei
    Ruan, Jianwei
    Qian, Yu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 3435 - 3447
  • [3] Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption
    Niu, Chenguang
    Xiao, Fei
    Yuan, Keyong
    Hu, XuChen
    Lin, Wenzhen
    Ma, Rui
    Zhang, Xiaoling
    Huang, Zhengwei
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [4] Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
    Qi, Dahu
    Liu, Hui
    Sun, Xuying
    Luo, Danni
    Zhu, Meipeng
    Tao, Tenghui
    Gao, Chenghao
    Zhou, Chuankun
    Zhou, Wei
    Xiao, Jun
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [5] Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades
    Song, Fangming
    Wei, Chengming
    Zhou, Lin
    Qin, An
    Yang, Mingli
    Tickner, Jennifer
    Huang, Yuanjiao
    Zhao, Jinmin
    Xu, Jiake
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (02) : 1723 - 1735
  • [6] Umbelliferone Prevents Lipopolysaccharide-Induced Bone Loss and Suppresses RANKL-Induced Osteoclastogenesis by Attenuating Akt-c-Fos-NFATc1 Signaling
    Kwak, Sung Chul
    Baek, Jong Min
    Lee, Chang Hoon
    Yoon, Kwon-Ha
    Lee, Myeung Su
    Kim, Ju-Young
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (11): : 2427 - 2437
  • [7] Niclosamide suppresses RANKL-induced osteoclastogenesis and prevents LPS-induced bone loss
    Cheon, Yoon-Hee
    Kim, Ju-Young
    Baek, Jong Min
    Ahn, Sung-Jun
    So, Hong-Seob
    Oh, Jaemin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 470 (02) : 343 - 349
  • [8] Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis
    Ye, Xiaoshuang
    Jiang, Juanjuan
    Yang, Juan
    Yan, Wenyan
    Jiang, Luyue
    Chen, Yan
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (08) : 1080 - 1089
  • [9] Triterpenoids from Potentilla chinensis Inhibit RANKL-Induced Osteoclastogenesis in Vitro and Lipopolysaccharide-Induced Osteolytic Bone Loss in Vivo
    Tran, Trong Trieu
    Gal, Minju
    Ha, Manh Tuan
    Hyun, Seungeun
    Kim, Okwha
    Lee, Jeong-Hyung
    Min, Byung Sun
    CHEMISTRY & BIODIVERSITY, 2025, 22 (03)
  • [10] Vitexin suppresses RANKL-induced osteoclastogenesis and prevents lipopolysaccharide (LPS)-induced osteolysis
    Jiang, Jiawei
    Jia, Yewei
    Lu, Xuanyuan
    Zhang, Tan
    Zhao, Kangxian
    Fu, Ziyuan
    Pang, Cong
    Qian, Yu
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 17549 - 17560
12345